Pfizer to launch late stage DMD gene therapy trial despite hospitalizations
May 15, 2020 at 08:01 AM EDT
Pfizer Inc said on Friday that a third patient had to be hospitalized after being treated with its experimental gene therapy for a rare degenerative muscular condition, but said the safety profile still supports launching a larger late-stage trial of the treatment.